Post covid 19 pulmonary fibrosis. Is it real threat?

After the COVID-19 outbreak, increasing number of patients worldwide who have survived COVID-19 continue to battle the symptoms of the illness, long after they have been clinically tested negative for the disease. As we battle through this pandemic, the challenging part is to manage COVID-19 sequela...

Descripción completa

Detalles Bibliográficos
Autores principales: Rai, Deependra Kumar, Sharma, Priya, Kumar, Rahul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tuberculosis Association of India. Published by Elsevier B.V. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654356/
https://www.ncbi.nlm.nih.gov/pubmed/34099197
http://dx.doi.org/10.1016/j.ijtb.2020.11.003
_version_ 1783608051587088384
author Rai, Deependra Kumar
Sharma, Priya
Kumar, Rahul
author_facet Rai, Deependra Kumar
Sharma, Priya
Kumar, Rahul
author_sort Rai, Deependra Kumar
collection PubMed
description After the COVID-19 outbreak, increasing number of patients worldwide who have survived COVID-19 continue to battle the symptoms of the illness, long after they have been clinically tested negative for the disease. As we battle through this pandemic, the challenging part is to manage COVID-19 sequelae which may vary from fatigue and body aches to lung fibrosis. This review addresses underlying mechanism, risk factors, course of disease and treatment option for post covid pulmonary fibrosis. Elderly patient who require ICU care and mechanical ventilation are at the highest risk to develop lung fibrosis. Currently, no fully proven options are available for the treatment of post inflammatory COVID 19 pulmonary fibrosis.
format Online
Article
Text
id pubmed-7654356
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Tuberculosis Association of India. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-76543562020-11-12 Post covid 19 pulmonary fibrosis. Is it real threat? Rai, Deependra Kumar Sharma, Priya Kumar, Rahul Indian J Tuberc Review Article After the COVID-19 outbreak, increasing number of patients worldwide who have survived COVID-19 continue to battle the symptoms of the illness, long after they have been clinically tested negative for the disease. As we battle through this pandemic, the challenging part is to manage COVID-19 sequelae which may vary from fatigue and body aches to lung fibrosis. This review addresses underlying mechanism, risk factors, course of disease and treatment option for post covid pulmonary fibrosis. Elderly patient who require ICU care and mechanical ventilation are at the highest risk to develop lung fibrosis. Currently, no fully proven options are available for the treatment of post inflammatory COVID 19 pulmonary fibrosis. Tuberculosis Association of India. Published by Elsevier B.V. 2021-07 2020-11-10 /pmc/articles/PMC7654356/ /pubmed/34099197 http://dx.doi.org/10.1016/j.ijtb.2020.11.003 Text en © 2020 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Rai, Deependra Kumar
Sharma, Priya
Kumar, Rahul
Post covid 19 pulmonary fibrosis. Is it real threat?
title Post covid 19 pulmonary fibrosis. Is it real threat?
title_full Post covid 19 pulmonary fibrosis. Is it real threat?
title_fullStr Post covid 19 pulmonary fibrosis. Is it real threat?
title_full_unstemmed Post covid 19 pulmonary fibrosis. Is it real threat?
title_short Post covid 19 pulmonary fibrosis. Is it real threat?
title_sort post covid 19 pulmonary fibrosis. is it real threat?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654356/
https://www.ncbi.nlm.nih.gov/pubmed/34099197
http://dx.doi.org/10.1016/j.ijtb.2020.11.003
work_keys_str_mv AT raideependrakumar postcovid19pulmonaryfibrosisisitrealthreat
AT sharmapriya postcovid19pulmonaryfibrosisisitrealthreat
AT kumarrahul postcovid19pulmonaryfibrosisisitrealthreat

Ejemplares similares